title: [Management of side effects of targeted therapies in renal cancer: cutaneous side effects].
abstract: Targeted therapies used (angiogenesis inhibitors and mTOR inhibitors) in advanced renal cell carcinoma have a constellation of reaction affecting the skin, hair and nails. This guideline describes the incidence, clinical presentation and treatment of dermatologic side effects that develop with the use of targeted therapies (sunitinib, sorafenib, pazopanib, bevacizumab, everolimus, temsirolimus).
authors.affiliation: Institut Gustave-Roussy, service de dermatologie, 39, rue Camille-Desmoulins, 94805 Villejuif Cedex, France. Electronic address: caroline.robert@igr.fr.
authors.forename: Caroline
authors.initials: C
authors.lastname: Robert
authors.affiliation: Medipole, chemin du Mas-Anglade, 66330 Cabestany, France.
authors.forename: Pierre
authors.initials: P
authors.lastname: Gimel
keywords: alopecia; alopécie; hand-foot syndrome; rash; syndrome main-pied